| TA242 |
Colorectal cancer (metastatic) 2nd line - cetuximab, bevacizumab and panitumumab (review) (TA242) |
|
-
-
Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of TA150 and part review of TA118)
NICE does not recommend cetuximab (on its own or in combination with chemotherapy) for people with metastatic colorectal cancer that has progressed (worsened) after first-line (first course) chemotherapy.
NICE does not recommend bevacizumab in combination with a fluoropyrimidine-based chemotherapy regimen for people with metastatic colorectal cancer that has progressed after first-line chemotherapy.
NICE does not recommend panitumumab on its own for people with metastatic colorectal cancer that has progressed after first-line chemotherapy.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE applies special considerations to treatments that can extend the lives of people who are nearing the end of their life.
Cetuximab does not provide enough benefit to patients to justify its high cost and did not qualify for special consideration.
There was no evidence available to assess whether bevacizumab in combination with a fluoropyrimidine-based chemotherapy regimen works for people with metastatic colorectal cancer that has worsened after first-line chemotherapy, so NICE could not recommend it.
Panitumumab does not provide enough benefit to patients to justify its high cost even when the special considerations were applied.
-
Other information
How this guidance was produced
Background information
- None found
This page was last updated: 24 January 2012
-
-
Guidance formats
Colorectal cancer (metastatic) 2nd line - cetuximab, bevacizumab and panitumumab (review)
Guideline for patients and carers (PDF)
-
Implementation tools and resources
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
